Clinical Trials - August 2, 2019
All patients have completed treatment in Sigrid Therapeutics’ trial
The company has announced that all patients have completed treatment with SiPore15 in the STAR Trial Development is well on track and top-line data will be reported in October this year, states the company in their press release. SiPore15 SiPore15 is a first-in-class medical device using specially engineered mesoporous silica particles (MSP) to achieve a […]
Clinical Trials - June 4, 2019
Rapid progress of Sigrid Therapeutics trial
The company has completed treatment of 25% of patients in the STAR trial of its medical device, SiPore15, and is well on track to finalize results by Q4 of this year. The company also reports that treatment compliance is good and the safety profile continues to look positive. STAR trial STAR aims to demonstrate that […]
Business Award - May 13, 2019
Sana Alajmovic hits GEN’s 2019 Top 10 Under 40
The international life sciences journal Genetic Engineering News (GEN) has placed Sana Alajmovic, CEO of Sigrid Therapeutics, on its Top 10 Under 40 of 2019, a list of rising stars making their mark in business and academia. The list casts its net internationally to identify emerging leaders among life sciences professionals working in a university, a […]
